Editor's Note Analysts say proposed tariffs on imported goods could increase costs for approximately 75% of medical devices marketed in the United States, 69% of which are manufactured solely abroad, according to a January 20 article in Medical Product Outsourcing. Valued at $197.8 billion in 2023, the US medical device…

Read More

Editor's Note Although medical device shortages threaten all patients, a recent FDA announcement highlights particular risks for pediatric populations who require size-appropriate equipment. “From ventilators and neonatal breathing tubes to hemodialysis catheters, the scarcity of these critical devices poses a growing threat to patient care – especially for our youngest…

Read More

Editor's Note US hospitals continue to face a shortage of intravenous (IV) fluids due to Hurricane-related damage to the Baxter manufacturing facility that was responsible for 60% of the nation’s supply, MedPage Today reported December 31. Citing a report from Baxter, the article notes that the manufacturer has restored eight…

Read More

Editor's Note Immigration and trade policies proposed by President-elect Donald Trump could exacerbate challenges with healthcare staff and medical supply chains, according to recent reporting from Modern Healthcare and The Hill. As detailed by Modern Healthcare, stricter immigration policies could impede efforts to recruit skilled international workers, exacerbating gaps in…

Read More

Editor's Note A Republican-led House subcommittee investigating the COVID-19 pandemic released a 520-page final report summarizing its two-year inquiry, outlining recommendations for future pandemic preparedness and critiquing both US and global responses to the crisis. CNN reported the news December 2. The report concludes that COVID-19 most likely emerged from…

Read More

Editor's Note A nationwide shortage of intravenous (IV) fluids is forcing hospitals to adopt conservation strategies that could reshape hydration practices long-term, KFF Health News reported November 19. The shortage was driven by Hurricane Helene’s damage to Baxter International’s North Cove facility, which is responsible for 60% of US IV…

Read More

Editor's Note The Biden administration has invoked wartime powers to speed rebuilding of intravenous fluid (IV) manufacturing capacity, CBS News reported October 15, four days after the US Food and Drug Administration (FDA) took steps to combat drug shortages. Both efforts are in response to devastation wrought by Hurricane Helene,…

Read More

Editor's Note Applying lessons learned from Hurricane Ian in 2022 helped Tampa General Hospital (TGH) successfully withstand Hurricane Helene in late September, according to an October 3 HealthLeaders interview with TGH CEO John Couris. Detailing how strategic preparations ensured the safety of its patients, staff, and critical infrastructure, including its…

Read More

Editor's Note In the wake of Hurricane Helene and the recent Gulf Coast port strikes, hospitals are raising alarms and pursuing their own strategies for mitigating supply chain disruption even as a second hurricane—Milton—bears down on Florida. As of October 7, dozens of Florida healthcare facilities had suspended services and/or…

Read More

Editor's Note Six US companies will manufacture approximately 250 million medical gowns as part of a government effort to shore up supplies that were subject to shortages during the COVID-19 pandemic, the Associated Press (AP) reported October 3. Led by the Administration for Strategic Preparedness and Response (ASPR), the initiative…

Read More